The effect of coronavirus disease-2019 (COVID-19) according to gender on health-related quality of life

Yıl 2022, Cilt: 5 Sayı: 4, 1030 - 1035, 20.07.2022

Betül Çiftçi

https://doi.org/10.32322/jhsm.1114579

Cited By: 1

Öz

Aim: The purpose of this study was to evaluate the changes in health-related quality of life of hospitalized patients with the diagnosis of coronavirus disease-2019 (COVID-19) according to gender.
Material and Method: The medical records of 77 patients (37 females and 40 males) who were hospitalized for COVID-19 were examined. Sociodemographic features including age, gender, marital status, comorbid diseases, duration of hospitalization, the period after discharge, symptoms of COVID-19 disease were analyzed. Short Form 36 (SF-36) was applied to all patients for evaluating the health-related quality of life pre and post COVID-19.
Results: The median scores of physical function, bodily pain, vitality, social functioning and general health perceptions before COVID-19 were statistically significantly higher than the scores after COVID-19 in both gender. Social functioning and the scores were lower in females than males for pre and post COVID-19 period and the differences were statistically significant.
Conclusions: The findings of this study revealed that health-related quality of life is affected by COVID-19 for both genders, mostly females.

Anahtar Kelimeler

Coronavirus, COVID-19, health-related quality of life, quality of life

Kaynakça

• T.C. Sağlık Bakanlığı . Covid-19 Genel bilgiler, epidemiyoloji ve tanı. Halk Sağlığı Genel Müdürlüğü. 2020;19 (COVID-19 (SARS-CoV-2 ENFEKSİYONU)): 1–32.
• WHO. WHO Coronavirus (COVID-19) Dashboard. 2022. Available from: https://covid19.who.int/
• Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 2020; 8: 420-2.
• Lai CC, Shih TP, Ko WC, Tang HJ, Hsueh PR. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. Int J Antimicrob Agents 2020; 55: 105924.
• Mutlu P, Mirici A, Gönlügür U, et al. Evaluating the clinical, radiological, microbiological, biochemical parameters and the treatment response in COVID-19 pneumonia. J Health Sci Med 2022; 5: 544-51.
• TC. İç işleri Bakanlığı. Sokağa çıkma yasağı genelgesi. 2021. Available online: https://www.icisleri.gov.tr/65-yas-ve-ustu-ile-kronik-rahatsizligi-olanlara-sokaga-cikma-yasagi-genelgesi.
• Szabo A, Ábel K, Boros S. Attitudes toward COVID-19 and stress levels in Hungary: Effects of age, perceived health status, and gender. Psychol Trauma 2020; 12: 572-5.
• Qiu J, Shen B, Zhao M, Wang Z, Xie B, Xu Y. A nationwide survey of psychological distress among Chinese people in the COVID-19 epidemic: implications and policy recommendations [published correction appears in Gen Psychiatr. 2020; 33: e100213corr1].
• Yezli S, Khan A. COVID-19 social distancing in the Kingdom of Saudi Arabia: Bold measures in the face of political, economic, social and religious challenges. Travel Med Infect Dis 2020; 37: 101692.
• Koçyigit H, Aydemir O, Olmez N, Memiş A. Reliability and validity of the Turkish version of Short-Form-36 (SF-36). Turkish J Drugs Ther 1999; 12: 102–6.
• Sanyaolu A, Okorie C, Marinkovic A, et al. Comorbidity and its Impact on Patients with COVID-19. SN Compr Clin Med 2020; 2: 1069-76.
• Kamal M, Abo Omirah M, Hussein A, Saeed H. Assessment and characterisation of post-COVID-19 manifestations. Int J Clin Pract 2021; 75: 0–2.
• Evans RA, McAuley H, Harrison EM, et al. Physical, cognitive, and mental health impacts of COVID-19 after hospitalisation (PHOSP-COVID): a UK multicentre, prospective cohort study. Lancet Respir Med 2021; 9: 1275–87.
• Vestbo J, Hurd SS, Agusti AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2013; 187: 347–65.
• Knight JS, Caricchio R, Casanova JL, et al. The intersection of COVID-19 and autoimmunity. J Clin Invest 2021; 131: e154886.
• Walsh SJ, Rau LM. Autoimmune diseases: A leading cause of death among young and middle-aged women in the United States. Am J Public Health 2000; 90: 1463–6.
• Richter AG, Shields AM, Karim A, et al. Establishing the prevalence of common tissue-specific autoantibodies following severe acute respiratory syndrome coronavirus 2 infection. Clin Exp Immunol 2021; 205: 99–105.
• Bastard P, Rosen LB, Zhang Q, et al. Autoantibodies against type I IFNs in patients with life-threatening COVID-19. Science 2020; 370: eabd4585.
• Caballero T, Prior N. Burden of Illness and Quality-of-Life Measures in Angioedema Conditions. Immunol Allergy Clin North Am 2017; 37: 597-616.
• Malik P, Patel K, Pinto C, et al. Post-acute COVID-19 syndrome (PCS) and health-related quality of life (HRQoL)-A systematic review and meta-analysis. J med virol 2022; 94: 253–62.
• van der Sar-van der Brugge S, Talman S, Boonman-de Winter L, et al. Pulmonary function and health-related quality of life after COVID-19 pneumonia. Respir Med 2021; 176: 106272.
• Tabacof L, Tosto-Mancuso J, Wood J, et al. Post-acute COVID-19 syndrome negatively impacts physical function, cognitive function, health-related quality of life, and participation. Am J Phys Med Rehabil 2022; 101: 48-52.
• Arab-Zozani M, Hashemi F, Safari H, Yousefi M, Ameri H. “Health-related quality of life and its associated factors in COVID-19 patients.” Osong Public Health and Research Perspectives 2020; 11: 296-302.
• Halpin SJ, McIvor C, Whyatt G, et al. Postdischarge symptoms and rehabilitation needs in survivors of COVID-19 infection: A cross-sectional evaluation. J Med Virol 2021; 93: 1013-22.
• Carfì A, Bernabei R, Landi F. Gemelli against COVID-19 post-acute care study group. persistent symptoms in patients after acute COVID-19. JAMA 2020; 324: 603-05.
• Valent A, Dudoignon E, Ressaire Q, Depret F, Plaud B. “Three-month quality of life in survivors of ARDS due to COVID-19: A preliminary report from a French academic centre.” Anaesth Crit Care Pain Med 2021; 39: 740-41.
• Moreno-Pérez O, Merino E, Leon-Ramirez JM, et al. Post-acute COVID-19 syndrome. Incidence and risk factors: A Mediterranean cohort study. J Infect 2021; 82: 378-83.
• Malik P, Patel K, Pinto C, et al. Post-acute COVID-19 syndrome (PCS) and health-related quality of life (HRQoL)-A systematic review and meta-analysis. J Med Virol 2022; 94: 253-62.
• Pappa S, Giannakoulis VG, Papoutsi E, Katsaounou P. Author reply - Letter to the editor "The challenges of quantifying the psychological burden of COVID-19 on heathcare workers". Brain Behav Immun 2021; 92: 209-10.
• Tull MT, Edmonds KA, Scamaldo KM, Richmond JR, Rose JP, Gratz KL. Psychological outcomes associated with stay-at-home orders and the perceived impact of COVID-19 on daily life. Psychiatry Res 2020; 289: 113098.
• Nguyen HC, Nguyen MH, Do BN, et al. People with suspected covid-19 symptoms were more likely depressed and had lower health-related quality of life: The potential benefit of health literacy. J Clin Med 2020; 9: 965.
• Xiao Y, Becerik-Gerber B, Lucas G, Roll SC. Impacts of working from home during COVID-19 pandemic on physical and mental well-being of office workstation users. J Occup Environ Med 2021; 63: 181–90.